Novel Hybrid Molecule with Both IOP Lowering and Neuroprotective Effects for Treatment of Glaucoma

Project Details

StatusActive
Effective start/end date1/03/20 → 31/08/25

Funding

  • NEI: National Eye Institute: $546,545.50